(KV) channels plays an important role in regulating pulmonary artery smooth muscle cell (PASMC) contraction, proliferation, and apoptosis. The highly conserved NH2-terminal tetramerization domain (T1) of KV channels is important for proper channel assembly, association with regulatory KV ␤-subunits, and localization of the channel to the plasma membrane. We recently reported two nonsynonymous mutations (G182R and E211D) in the KCNA5 gene of patients with idiopathic pulmonary arterial hypertension, which localize to the T1 domain of KCNA5. To study the electrophysiological properties and expression patterns of the mutants compared with the wild-type (WT) channel in vitro, we transfected HEK-293 cells with WT KCNA5, G182R, E211D, or the double mutant G182R/E211D channel. The mutants form functional channels; however, whole cell current kinetic differences between WT and mutant channels exist. Steady-state inactivation curves of the G182R and G182R/E211D channels reveal accelerated inactivation; the mutant channels inactivated at more hyperpolarized potentials compared with the WT channel. Channel protein expression was also decreased by the mutations. Compared with the WT channel, which was present in its mature glycosylated form, the mutant channels are present in greater proportion in their immature form in HEK-293 cells. Furthermore, G182R protein level is greatly reduced in COS-1 cells compared with WT. Immunostaining data support the hypothesis that, while WT protein localizes to the plasma membrane, mutant protein is mainly retained in intracellular packets. Overall, these data support a role for the T1 domain in channel kinetics as well as in KCNA5 channel subcellular localization.
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voltage-gated K ϩ channels; T1 domain; pulmonary arterial hypertension; KV1.5 POTASSIUM ION (K ϩ ) channels are ubiquitously expressed in cells as diverse as vascular smooth muscle cells, cardiomyocytes, neurons, and immune cells. They have been implicated in a number of functions, including repolarization after action potential (18) , apoptosis (5, 6, 23) , regulation of resting membrane potential (E m ) (1, 43, 45, 73) , and volume regulation (51, 66, 70) . In pulmonary artery smooth muscle cells (PASMC), the activity of K ϩ channels, notably voltage-gated K ϩ (K V ) channels, plays a large role in setting resting E m (1, 43, 60, 73, 76 (73) , which can lead to contraction and proliferation (3, 15, 42, 48) .
Functional classification recognizes four divisions of K ϩ channels: K V channels, Ca 2ϩ -sensitive K ϩ (K Ca ) channels, inwardly rectifying K ϩ (K IR ) channels, and two-pore domain K ϩ (K 2P ) channels. K V channels are further divided into subfamilies, K V 1-K V 12 (KCNA-KCND, KCNF-KCNG, KCNQ, KCNV, KCNS, and KCNH, which includes K V 10, K V 11, and K V 12), and in mammals K V channels alone are represented by over 70 genes (17) . Functional K V channels are composed of four pore-forming ␣-subunits (K V ␣) that can form either homo-or heterotetramers, although certain restrictions on heteromultimerization within subfamilies have been observed in vivo (33, 49, 57) . Subunit composition of the channel can also influence cell surface expression (33) . Various domains of K V subunits play a role in channel assembly (2, 61, 79) , but perhaps the most widely studied is the cytoplasmic NH 2 -terminal tetramerization (T1) domain.
The T1 domain is ϳ90 -120 amino acids in length and highly conserved, demonstrating 76 -90% amino acid identity within the K V 1 (KCNA) subfamily. Present in all K V channels, the T1 domain is involved in K V ␣-K V ␣ recognition and is largely responsible for tetramerization (25, 28, 56, 57, 68) . T1 domains also govern channel interaction with cytoplasmic regulatory ␤-subunits (K V ␤) (55, 71) . Single point mutations in this domain have been shown to disrupt both K V ␣-K V ␣ and K V ␣-K V ␤ interactions (4, 55, 57, 68) . Crystallization studies have revealed that T1-T1 interactions, and thus channel assembly, rely largely on polar interactions of conserved amino acids in this domain (22) . Multimerization of channel subunits through T1 interactions is thought to occur early in the biosynthetic pathway when nascent K V 1 channel subunit is still attached to the ribosome and/or in the sarcoplasmic (SR) or endoplasmic (ER) reticulum membrane (10, 32, 41, 54) . Interestingly, T1 monomers from K V 1.3 (KCNA3) start acquiring compact structures in the ribosomal tunnel that correspond to ␣-helices of K V 1 (KCNA) crystal structures (21) . Thus deficiencies in T1 function may have effects on K V channel protein as early as NH 2 -terminal emergence from the ribosome.
The T1 domain is also involved in association of K V ␣ subunits with regulatory K V ␤ subunits (27, 55, 71) , which have been shown to alter activation and inactivation kinetics, gating, redox sensitivity, and sensitivity to protein kinase modulation of K V channels, thus contributing to the diversity of K ϩ currents. Most notably, K V ␤ subunits confer N-type inactivation on KCNA5 channels (and other KCNA channels) (26, 35, 52, 62, 63, 67) . Association between K V ␣ and K V ␤ subunits, like that among different K V ␣ subunits, demonstrates some specificity between subfamilies (53). Furthermore, K V ␣-K V ␤ association occurs early in the biosynthetic pathway and has been shown to increase expression of channels in the plasma membrane (7, 13, 33, 41, 58) , although residues within the channel pore region may also control surface expression of KCNA channels (34, 79) .
In addition to its role in channel formation and association with K V ␤ subunits, the T1 domain has also been implicated in various other aspects of channel function. T1 domains are linked by an ␣-helical linker to the membrane-spanning S1 domain, thus creating side portals between the T1 domain and the pore (29) . Multiple negatively charged amino acids on the surface of the side portal may attract cations to the pore region (29) . Additionally, the T1 domain influences gating properties and voltage sensitivity of K V channels (8, 9, 39) .
We recently reported (50) two naturally occurring nonsynonymous mutations in the KCNA5 gene (which map to the T1 domain of the KCNA5 channel) in patients with idiopathic pulmonary arterial hypertension (IPAH), a life-threatening disease that affects 2 to 5 million people per year and leads to right heart failure and death if left untreated (38) . These mutations occur at highly conserved residues and are therefore expected to affect channel function. Because the T1 domain is involved in channel assembly (specifically through polar interfaces of the T1 domain), association with K V ␤ subunits, and various aspects of gating, both the G182 and E211 residues may play a critical role in regulating the channel's biophysical, pharmacological, and molecular characteristics. We report here the effects of these naturally occurring mutations on KCNA5 channel kinetics as well as protein expression levels. It has to be emphasized that we do not intend to suggest that these two mutations are associated with the pathogenesis of IPAH or are the cause for the decreased KCNA5 expression and decreased I K(V) in PASMC from IPAH patients we previously reported (72, 75) , as such studies would require a large number of patient samples.
MATERIALS AND METHODS
Protein modeling. KCNA5 (KV1.5) has 77% amino acid identity to KCNA2 (K V1.2). On the basis of previous X-ray crystallographic data of KCNA2 (PDB IDs 2a79, 1qdw, 1qdv, and 1dsx) and structural homology comparisons with short peptide sequences for the divergent sequences of KCNA5, the protein modeling software InsightII (Accelrys, San Diego, CA) was used to model KCNA5 and to determine the relative orientations of the mutant side chains.
Cell culture and transfection. All cells were maintained in a humidified environment at 37°C and 5% CO 2. Cells were split with trypsin on reaching 70 -90% confluence. HEK-293 and COS-1 cells (American Type Culture Collection) were maintained in DMEM supplemented with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine, while PASMC were cultured in smooth muscle growth medium (Lonza). For electrophysiological recordings, Western blotting, and coimmunoprecipitation (Co-IP) studies, cells were transiently transfected at 50 -80% confluence 2-3 days after being plating with Lipofectamine 2000 according to the manufacturer's instructions with the modification that cells were incubated with the transfection reagent-DNA complex for only 4 h to preserve cell membrane integrity and cell viability. Western blots and Co-IPs were performed 24 h after transfection, while electrophysiological measurements were taken 24 -72 h after transfection. For immunostaining, cells plated on glass coverslips were transfected with Fugene 6 (Roche) because of sustained adhesion difficulties with Lipofectamine 2000. The Fugene (l)-to-DNA (g) ratio was 3:2, and the efficiency was 20 -50%.
Wild-type and mutant (G182R, E211D, and G182R/E211D) KCNA5 constructs and K V␤ construct. The PCMS-EGFP vector (Clontech), common to all KCNA5 constructs used in these experiments, is a bicistronic expression vector that expresses the KCNA5 gene (or the mutant version of the gene) and enhanced green fluorescent protein (EGFP) under two different promoters. Wild-type (WT) KCNA5-EGFP (WT KCNA5) (5) was used to make the three mutant constructs (with the nucleotide mutation and position indicated) KCNA5(773 g/a)-EGFP (G182R), KCNA5(862 g/c)-EGFP (E211D), and KCNA5(773 g/a; 862 g/c)-EGFP (G182R/E211D) with Stratagene's QuikChange II (XL) Site-Directed Mutagenesis Kit according to the manufacturer's instructions. The gel-purified EcoRI-NotI fragment of WT-KCNA5 was subcloned into pBluescript SK (pBSSK, Stratagene). After verification of the identity and integrity of the insert by sequencing, KCNA5-pBSSK was subjected to mutagenesis with the following cycling parameters: 95°C for 30 s, followed by 20 cycles of 95°C for 30 s, 55°C for 1 min, and 68°C for 7 min. There is a naturally occurring ClaI restriction site at position 1190 of the KCNA5 coding sequence. The EcoRI-ClaI fragment of the mutated KCNA5-pBSSK and the ClaI-NotI fragment of the original KCNA5-pBSSK were subcloned into the pCMS-EGFP vector. DNA purified from transformed colonies was sequenced to verify the presence of the mutation and the integrity of the insert. The following primer pairs were used for site-directed mutagenesis: G182R: 5=-CTACTACTACCAGTCCcGGGGCCGgCTGCGGAGGCCGGTC-3=/5=-GACCGGCCTCCGCAGcCGGCCCCgGGACTGGTAGTAGTAG-3= and E211D: 5=-GACGAGGCCATGGAcCGgTTCCGCGAGGATGAG-3=/5=-CTCATCCTCGCGGAAcCGgTCCATGGCCTCGTC-3= (lowercase letters indicate a DNA mutation; mutations that result in amino acid substitutions are in bold; the silent mutations were inserted to create NaeI and AgeI diagnostic restriction sites, which are underlined). The KV␤1.3-HA construct, which expresses K V␤1.3 (KCNAB1) with a hemagglutinin (HA) tag at its NH2 terminus, was kindly provided by Dr. Katherine T. Murray (Vanderbilt University) (67) .
Solutions for electrophysiology. All chemicals were purchased from Sigma unless otherwise indicated. External solution was perfused through the recording chamber at 2 ml/min. The external solution for recording whole cell IK(v) contained (in mM) 141 NaCl, 4.7 KCl, 3 MgCl 2, 1 EGTA, 10 glucose, and 10 HEPES and was adjusted to pH 7.4 with NaOH. The internal (pipette) solution contained (in mM) 135 KCl, 4 MgCl 2, 10 HEPES, 10 EGTA, and 5 Na 2ATP, and pH was adjusted to 7.2 with KOH. 4-Aminopyridine (4-AP, 5 mM) was directly dissolved in external solution, and pH was readjusted to 7.4 with NaOH.
Electrophysiology and pulse protocols. Cells were subjected to standard electrophysiological techniques with an Axopatch-1D amplifier and a Digidata 1322A interface (Axon Instruments) as described previously (74) . Patch pipettes fabricated from borosilicate glass tubes (Sutter Instruments) were pulled on a P-97 electrode puller (Sutter Instruments) and fire polished to resistances of 2-4 M⍀. Pipettes were used to make high-resistance (2-8 G⍀) seals with cell membranes before cell break-in for whole cell recordings. The series resistance and membrane capacitance were compensated in all experiments with the patch-clamp amplifier. Pulse protocols and data acquisition were performed with pCLAMP 8.2 (Axon Instruments). The whole cell pulse protocol for recording current-voltage (I-V) relationships, including those in response to 4-AP, started at a holding potential of Ϫ70 mV with 300-ms steps in 20-mV increments from Ϫ80 to ϩ60 mV. P/4 subtraction was used to subtract leakage and capacitance currents. Inactivation protocols started with a holding potential of Ϫ70 mV, followed by a 10-s prepulse to potentials between Ϫ90 mV and ϩ60 mV in 10-mV increments, 5 ms at holding potential, and a 150-ms test pulse to ϩ60 mV.
Western blot and coimmunoprecipitation. Cells were lysed in 580 l of lysis buffer (1% Triton X-100, 150 mM NaCl, 5 mM EDTA, and 50 mM Tris · HCl, pH 7.4) supplemented with 7ϫ protease inhibitor cocktail (Roche) and 100 g/ml phenylmethylsulfonyl fluoride (PMSF). Lysates were kept on ice for 10 min and then centrifuged at 4°C and 14,000 rpm for 15 min. The insoluble fraction was discarded, and Laemmli Sample Buffer (Bio-Rad) with 10% ␤-mercaptoethanol was added to the soluble fraction in a 2-to-1 ratio. Samples were vortexed briefly and boiled at 100°C for 5 min. Protein samples were separated on a 4 -20% Tris-glycine gel (Invitrogen) and transferred to nitrocellulose membranes (Whatman). Membranes were incubated in blocking buffer (5% nonfat dry milk powder, 0.1% Tween 20) for 1 h and subsequently incubated overnight with anti-K V1.5 antibody (Alomone Labs) at a dilution of 1:600 at 4°C. Membranes were washed twice in TBS-T (37 mM NaCl, 15.4 mM Trizma HCl, 4.6 mM Tris base, 0.001% Tween 20) and incubated with goat anti-rabbit IgG-horseradish peroxidase (HRP) (Santa Cruz) secondary (1:2,000) for 1 h at room temperature. After two washes in TBS-T, membranes were exposed to SuperSignal Chemiluminescent substrate for HRP (Pierce) for 5 min and developed (Ͻ1 s) on BioMax Light Film (Kodak). Membranes were reprobed for GAPDH (Chemicon, 1:500). Films were scanned, and the intensities of the bands were analyzed with ImageJ software (National Institutes of Health).
For Co-IP, 5% of the total cell lysate was run as a loading control. The rest of the lysate was incubated with 1:160 anti-K V1.5 antibody (Alomone) for 45 min on ice. Protein A/G beads (Pierce) were then added, and the mixture was gently rocked for 1 h at 4°C. The unbound fraction was washed four times in ice-cold lysis buffer. Subsequent preparation of the protein fraction for loading onto the gel followed the procedure for Western blots. Membranes were probed with an anti-HA-tag antibody (Santa Cruz).
Reverse transcriptase PCR. Total RNA was isolated from COS-1 cells with a standard TRIzol (Invitrogen) and chloroform extraction and subjected to standard reverse transcriptase PCR (RT-PCR) with the SuperScript First-Strand cDNA Synthesis kit (Invitrogen) according to the manufacturer's instructions. cDNA was subjected to PCR with the Platinum PCR SuperMix High Fidelity reagent (Invitrogen). The PCR protocol was as follows: 3 min at 94°C followed by 32 cycles of (30 s at 94°C, 30 s at 55°C, and 30 s at 72°C), followed by 10 min at 72°C and then hold at 4°C. The sequences of sense and antisense primers (Table 1) were designed from the coding regions of human KCNA5 subunits. Primer fidelity and specificity were examined with the NCBI BLAST program. PCR products were visualized on a 1.5% agarose gel with 0.008% Gel Star Nucleic Acid Gel Stain (Cambrex). Net intensity values of the PCR product bands, measured with a Kodak Electrophoresis Documentation System (Eastman Kodak, Rochester, NY), were normalized to GAPDH ( Table 1) . The ratios are expressed in arbitrary units (a.u.) for quantitative comparisons.
Immunostaining. COS-1, HEK-293, or human PASMC were washed on ice three times with PBS. After cells were fixed in 4% paraformaldehyde-PBS for 15 min at room temperature, coverslips were incubated in blocking solution (2% BSA, 2% FBS, 0.1% Triton X-100 in PBS) for 1 h. Coverslips were then exposed to rabbit anti-K V1.5 antibody (Alomone Labs) at a dilution of 1:100 in blocking solution for 2 h at room temperature. After a PBS wash, cells were incubated with bovine anti-rabbit rhodamine-conjugated IgG antibody (Santa Cruz, 1:1,000) for 45 min. Cells were also stained with 4=,6=-diamidino-2-phenylindole (DAPI; Invitrogen) to label nuclei. After washing in PBS, coverslips were mounted onto glass slides with Fluoromount-G (Electron Microscopy Sciences) and visualized under appropriate fluorescent filters on a Nikon inverted light microscope or on a Olympus IX70 Deconvolution microscope.
Statistical analysis. The composite data are expressed as means Ϯ SE. Statistical analysis was performed with the unpaired Student's t-test or one-way analysis of variance (ANOVA) as indicated. Differences were considered to be significant when P Ͻ 0.05.
RESULTS

Protein modeling reveals orientation of G182R and E211D
residues. We recently reported (50) two nonsynonymous mutations in the KCNA5 gene, g773a and g862c, that were identified in some IPAH patients but neither in normal subjects nor in normotensive patients. These mutations, which encode for a glycine (G) to arginine (R) mutation at amino acid 182 (ggg ¡ agg; G182R) and a glutamate (E) to aspartate (D) mutation at residue 211 (gag ¡ gac; E211D), localize to the NH 2 -terminal tetramerization domain (T1) of KCNA5 ( Fig. 1 , A and B). Both the G182R and E211D mutations occur at highly conserved residues within the T1 domain. The glycine at position 182 is 100% identical in the T1 domains of all 17 human KCNA (K V 1), K V 2 (KCNB), K V 3 (KCNC), and K V 4 (KCND) subunits examined (KCNA1-7, KCNA10, KCNB1-2, KCNC1-4, and KCND1-3), while the glutamate residue at position 211 is ϳ60% identical over these subunits (Fig. 1C) . Interestingly, KCNA10 has a naturally occurring aspartate residue (D) at this location. However, the function of any particular residue within the polar interfaces of the T1 domain may rely on the specific local environment conferred by the rest of T1.
In addition to the two patients in which each of the G182R and E211D mutations were previously reported (50), we screened 234 additional IPAH patients and 184 normotensive subjects for nonsynonymous mutations in the NH 2 -terminal regions of KCNA1-KCNA6 and KCNA10. The g/c mutation that encodes E211D in KCNA5 was found in nine additional IPAH patients and zero normotensive subjects. Furthermore, we found the G182R mutation in one IPAH patient's KCNA3 gene and not in any normotensive subjects. We also found a novel single nucleotide polymorphism (SNP) that encodes a valine to methionine amino acid substitution at position 220 (V220M) of KCNA10 in 30 IPAH patients and 23 control subjects (3 subjects were homozygous for the minor variant).
It was of initial interest to determine the orientation G182R and E211D would adapt in the assembled KCNA5 protein.
However, a complete model of KCNA5 is lacking, and much information about mammalian K V channel structure is based on KCNA2 (29 -31) . The G182R mutation introduces a long positively charged side chain (3 carbon atoms and a guani- ) in place of a hydrogen atom, while the E211D mutation shortens the side chain of the carboxyl group from two carbons to one. On the basis of previous X-ray crystallographic data of KCNA2, we created a putative model of KCNA5 to determine the relative orientations of the mutant side chains (Fig. 1D) . The model of the WT KCNA5 protein indicates that both the G182 and E211 residues are close to the ion permeation pathway (Fig. 1Da) . Specifically, G182 is located on an outward facing loop between two ␣-helices within the cytoplasmic core of T1 (Fig. 1D, b and c) . The acidic side chain of E211 faces outward from the region just upstream of the T1-S1 linker close to the intracellular opening of the pore (Fig. 1D, a and c) . The positively charged guanidinium group introduced by G182R protrudes beyond the surface of the WT T1 interface; furthermore, the E211D mutation buries the negatively charged carboxyl group within the surface of the T1 domain (Fig. 1Dc) . Because polar interfaces in the T1 domain mediate K V channel assembly and interaction with modulatory proteins, these mutations were expected to affect channel function. Thus we were interested in studying the effects of both mutations, as well as the doubly mutant KCNA5 channel (G182R/E211D).
G182R, E211D, and G182R/E211D mutant subunits form functional KCNA5 channels. We were initially interested in determining whether the mutant proteins could form functional channels. While K V channel dysfunction in PASMC has been linked to IPAH, PASMC from normal subjects express high levels of endogenous KCNA5 relative to other cell types (e.g., HEK-293 and COS-1 cells) ( Fig. 2A) . Therefore, an expression system that would allow the study of the effects of the G182R and E211D mutations in isolation was needed. Both (mammalian) COS-1 and (human) HEK-293 cells express low endog- enous levels of KCNA5 ( Fig. 2A, GFP lanes) . However, KCNA5 protein is readily detectable on immunoblot in cells transfected with WT KCNA5 (Fig. 2A, WT lanes) . Transfected and untransfected cells were also subjected to a standard electrophysiological protocol (Fig. 2B ) to measure whole cell I K(V) . I K(V) in untransfected COS-1 and HEK-293 cells is low (Fig. 2B) . For example, water (mock)-transfected HEK-293 cells have a peak I K(V) of 0.52 Ϯ 0.13 nA at ϩ60 mV (Fig. 2B) , whereas transfection of WT KCNA5 leads to a peak I K(V) of 14.08 Ϯ 0.84 nA (n ϭ 15) (Fig. 2, B-E) . Thus the majority of experiments were conducted in HEK-293 and COS-1 cells.
Because of the high conservation of the residues at positions 182 and 211 and the essential role of the T1 domain in channel formation, there was a possibility that the mutant proteins would not form functional KCNA5 channels. We transiently transfected HEK-293 cells with water (mock), the empty vec- (Fig. 2D, bottom) . There was no significant difference in I K(V) amplitude among HEK-293 cells transfected with WT KCNA5, G182R, E211D, or G182R/E211D (Fig. 2, D and E) . For example, at ϩ60 mV, steady-state currents for cells transfected with WT KCNA5 were 14.08 Ϯ 0.84 nA (n ϭ 15), while cells transfected with G182R, E211D, or G182R/E211D had steady-state current amplitudes of 13.95 Ϯ 0.54 (n ϭ 15), 12.61 Ϯ 0.79 (n ϭ 14), and 12.90 Ϯ 0.99 (n ϭ 16) nA, respectively (Fig. 2D, bottom) . Additionally, I K(V) from HEK-293 cells transfected with WT KCNA5 or G182R, E211D, or G182R/E211D demonstrated similar activation thresholds at Ϫ40 mV (Fig. 2, D, bottom, and E) . In comparison with mock-transfected cells, these results indicate that currents recorded in HEK-293 cells transfected with WT-KCNA5, G182R, E211D, or G182R/E211D arise from the transfected channel. Thus G182R, E211D, and G182R/E211D proteins are able to form homotetrameric KCNA5 channels and generate K V currents through KCNA5 channels. 
T1 mutations alter inactivation kinetics of KCNA5 currents in transfected HEK-293 cells. Differences in KCNA5 current
(I KCNA5 ) kinetics were observed in the I-V curves between WT and mutant KCNA5 and led to the further examination of current kinetics in these mutant channels. We examined steady-state inactivation with a standard two-pulse protocol in which the prepulse (t 1 ) was 10 s in duration (Fig. 3Aa,  bottom) . We recorded I KCNA5 from HEK-293 cells transfected with WT-KCNA5, G182R, E211D, or G182R/E211D (Fig.  3A) . While the WT KCNA5 channel shows some inactivation over 10 s, especially at more positive potentials (e.g., ϩ60 mV), this is more apparent in the G182R and G182R/E211D traces (Fig. 3A) . The current observed during the test pulse (t 2 ) from Ϫ40 to ϩ60 mV is indicative of the relative availability of the channels after inactivation. At 0 mV of t 1 potential, the availability of channels, determined by the ratio of the amplitude of I KCNA5 during the test potentials (I t2 ) to the amplitude of I KCNA5 during the prepulse potential (I t1 ), was 72.83 Ϯ 3.99% for WT KCNA5, 53.57 Ϯ 6.00% for G182R (P Ͻ 0.05 vs. WT), 73.49 Ϯ 3.31% for E211D (P ϭ 0.90 vs. WT), and 37.01 Ϯ 4.97% for G182R/E211D (P Ͻ 0.001 vs. WT) (Fig. 3Ba) .
Plotting the ratio of the amplitude of steady-state I KCNA5 during the test pulse (I t2 ) to the amplitude of the steady-state current during the prepulse (I t1 ) against the prepulse potential gives the steady-state inactivation curve (Fig. 3B, a and b) . Fitting the curves to Boltzmann equations of the form
where V represents the prepulse potential and k the steepness of voltage dependence of inactivation) allowed the determination of the V 1/2 inactivation values. The leftward shift in the steady-state inactivation curves of both the G182R and G182R/E211D channels is apparent from the comparisons of their steady-state inactivation curves and the V 1/2 values calculated from the fitted curves [WT KCNA5, 17.11 mV (n ϭ 12); G182R, 5.46 mV (n ϭ 12); and G182R/E211D, Ϫ4.39 mV (n ϭ 14)] (Fig. 3B, top and  bottom) . No difference between WT KCNA5 and E211D was observed [V 1/2 ϭ 19.03 mV (n ϭ 12)] (Fig. 3B, middle) . Overall, these data indicate that the G182R mutation causes the KCNA5 channel to be more easily and rapidly inactivated compared with WT KCNA5 channels.
Neither G182R nor E211D mutations affect KCNA5 inhibition by 4-AP. We next sought to determine whether inhibition of the mutant channels by 4-AP, a K V channel blocker, differed from the WT channel's response. I KCNA5 was recorded in transiently transfected HEK-293 cells before, during, and after administration of 5 mM 4-AP in the bathing solution (Fig. 4A) . 4-AP significantly and reversibly inhibited I KCNA5 in HEK-293 cells transfected with WT KCNA5 channel (Fig. 4Aa) . For example, at ϩ60 mV, I KCNA5 in these cells was 14.08 Ϯ 0.84 nA (n ϭ 15). On administration of 4-AP there was 67% inhibition, with an I KCNA5 amplitude of 4.60 Ϯ 0.29 nA, and on washout I KCNA5 recovered to 95% of its original value (13.35 Ϯ 0.84 nA) (Fig. 4Aa) . Thus 5 mM 4-AP significantly and reversibly inhibits I KCNA5 in HEK-293 cells transiently transfected with WT KCNA5.
In cells transiently transfected with G182R, E211D, or G182R/E211D mutants, I KCNA5 shows inhibition and recovery similar to those of the WT channel (Fig. 4A, b-d) . At ϩ60 mV in cells transfected with G182R, control I KCNA5 amplitude was 14.13 Ϯ 0.78 nA (n ϭ 8), while it decreased to 3.35 Ϯ 0.49 nA (24% of control I KCNA5 ) during exposure to 4-AP and recovered to 12.71 Ϯ 0.79 nA (90% of control I KCNA5 ) after washout (Fig. 4Ab) . In cells transfected with the E211D channel, control I KCNA5 was 13.44 Ϯ 0.99 nA (n ϭ 8), decreased to 3.74 Ϯ 0.46 nA during 4-AP administration (28% of control I KCNA5 ), and recovered to 11.83 Ϯ 1.06 nA (88% of control I KCNA5 ) (Fig.  4Ac) . Similarly, in cells transfected with the G182R/E211D Fig. 3 . Voltage-dependent inactivation is accelerated in the G182R mutant KCNA5 channel. A standard 2-pulse inactivation protocol was used to determine channel availability after a 10-s prepulse in HEK-293 cells transiently transfected with WT KCNA5, G182R, E211D, or G182R/E211D. A: representative recordings of currents, elicited by prepulse (t1) and test pulse (t2) from cells transfected with the indicated vector are shown in a; the recordings of the currents elicited by t2 are enlarged and shown in b. B: inactivation curves (a) are plotted as current amplitude during test pulse (It2) over the amplitude during prepulse (It1) against the prepulse potential (It2/It1). The Boltzmann equation was used to fit the inactivation curves and determine V1/2 (b). All data are presented as means Ϯ SE. WT KCNA5, n ϭ 12; G182R, n ϭ 12; E211D, n ϭ 12; G182R/E211D, n ϭ 14. *P Ͻ 0.05, ***P Ͻ 0.001 vs. WT KCNA5.
channel, control I KCNA5 was 15.90 Ϯ 1.06 nA (n ϭ 8), while 4-AP reduced currents to 37% (5.82 Ϯ 0.82 nA) and I KCNA5 nearly fully recovered after washout (15.22 Ϯ 0.98 nA, 96% of control I KCNA5 ) (Fig. 4Ad) . Thus, at ϩ60 mV, 4-AP blocks ϳ75% I KCNA5 in cells transfected with WT KCNA5, G182R, E211D, or G182R/E211D channels (Fig. 4B) and I KCNA5 recovered to ϳ90% of its original value after washout. No significant differences were observed regarding 4-AP inhibition between HEK-293 cells transfected with WT KCNA5 and the mutant G182R, E211D, or G182R/E211D channels.
G182R mutation causes incomplete processing of KCNA5 in HEK-293 cells. The G182R and E211D mutations are located in the conserved T1 domain, which has been implicated in channel assembly and localization to the plasma membrane. As such, protein expression levels and subcellular localization patterns of WT KCNA5, G182R, E211D, and G182R/E211D channels were examined in HEK-293 cells. Whole cell protein lysates from HEK-293 cells transfected with WT KCNA5, G182R, E211D, or G182R/E211D channels were subjected to immunoblot to detect KCNA5 (Fig. 5A ). We noted a trend toward decreased G182R/E211D protein compared with WT KCNA5 (0.72 Ϯ 0.10 a.u., n ϭ 13), although this difference was not statistically significant (Fig. 5B) . Neither the G182R (0.97 Ϯ 0.11 a.u., n ϭ 13) nor the E211D (0.90 Ϯ 0.12 a.u., n ϭ 13) total protein expression levels differed from WT KCNA5 (n ϭ 13, Fig. 5B ). In cells transfected with water (mock), endogenous KCNA5 levels were low (0.31 Ϯ 0.05 a.u., n ϭ 13), as expected (see Fig. 2A, left and center) . These results must be interpreted cautiously, because the experiments are not strictly quantitative. We noted, however, that the more prominent difference between WT KCNA5 and mutant protein was the ratios of the upper and lower bands (Fig. 5C ). Many KCNA channels, including KCNA1 (K V 1.1), KCNA2 (K V 1.2), and KCNA4 (K V 1.4), are glycosylated on the extracellular loop between S1 and S2 (10, 56, 59) . Early core partial glycosylation (of the Drosophila Shaker channel) in the ER is followed by processing of the sugar residues into their mature form in the Golgi apparatus (41) . On immunoblot of KCNA subunits, a lower electrophoretic mobility (lighter) suggests an ER pool of immature protein, whereas a higher mobility (heavier) is indicative of sialylated (mature) complexes present in the Golgi and at the plasma membrane (33) . Like other KCNA subunits, KCNA5 has an extracellular glycosylation site between S1 and S2. Thus KCNA5 can appear as a doublet on immunoblots, where the upper band represents the mature sialylated form while the lower band represents the immature high-mannose N-linked oligosaccharide form (59) .
WT KCNA5 protein was present as a doublet, although most protein was present in the upper band (upper-to-lower band ratio 2.23 Ϯ 0.41, n ϭ 7) (Fig. 5, A and C) . However, all three mutant channels were also detected as doublets with prominent lower bands (Fig. 5, A and C) . The G182R/E211D protein had a significantly lower ratio (1.04 Ϯ 0.23, n ϭ 7, P Ͻ 0.05) (Fig.  5C ) compared with WT KCNA5. The G182R ratio (1.28 Ϯ 0.25, n ϭ 7) was similar to that of G182R/E211D and was also found to be statistically significant (Fig. 5C ). Although the ratio for the E211D channel (1.67 Ϯ 0.51, n ϭ 7) was lower than that of WT KCNA5, this difference was not statistically significant (Fig. 5C ). These data suggest that, while most WT KCNA5 protein is processed into its mature form, the G182R mutation causes more of the protein to be present in its immature form.
Subcellular localization of WT and mutant KCNA5 channels. To examine the effects of the G182R and E211D mutations on KCNA5 subcellular localization, transfected HEK-293 cells were subjected to standard immunocytochemical staining to detect KCNA5 (Fig. 6, red) . Green fluorescence was used as a marker of individual transfected cells, and DAPI (blue) was used as a nuclear stain (Fig. 6) . HEK-293 cells transfected with WT KCNA5 demonstrate two distinct patterns of staining: cell surface staining is visible as positive staining around the perimeter of the cell, and distinct perinuclear packets of WT KCNA5 are also visible (Fig. 6A, a and c) . These data are consistent with immunoblot data suggesting that transfected WT KCNA5 protein is present both in its mature form at the cell surface and in its immature form. HEK-293 cells transfected with G182R demonstrate predominantly perinuclear staining, and surface staining from these cells is notably reduced (Fig. 6A, b and d) . Similar to HEK-293 cells transfected with WT KCNA5, cells transfected with either E211D or G182R/E211D demonstrate both perinuclear and cell surface staining patterns, although perinuclear populations appear more prevalent than the surface staining (data not shown). HEK-293 cells transfected with water (mock) confirm both low endogenous KCNA5 expression and anti-KCNA5 antibody specificity (Fig. 6Ba) , while HEK-293 cells transfected with WT KCNA5 and incubated without anti-KCNA5 antibody confirm secondary antibody specificity (Fig. 6Bb) . These data are consistent with the hypothesis that the G182R mutation causes incomplete processing of the KCNA5 protein, which may lead to a decrease of its expression on the cell surface.
We were interested in determining the effects of the mutations on subcellular localization of KCNA5 in a more physiologically relevant environment. Therefore, we used transfected human PASMC to examine the localization of KCNA5. Although human PASMC express endogenous KCNA5 (Fig. 2A) , it was expected that transfected KCNA5 would tetramerize with endogenous protein, thus forming a population of channels composed of at least one exogenous subunit. Because the subcellular localization of K V channels may be determined by a single subunit acting in a dominant manner (14, 33) , it was possible that transfected G182R, E211D, or G182R/E211D protein would affect the localization of this subset of KCNA5 channels in human PASMC. Human PASMC transfected with WT KCNA5 have a dispersed pattern of staining, with KCNA5 located throughout the cell as well as on the perimeter, indicative of cell surface localization (Fig. 6Ca) . When human PASMC transfected with G182R or E211D were examined, however, it appeared that most KCNA5 was found in packets around the nucleus (data not shown). On the basis of the preliminary data, the G182R/E211D mutant channels were observed in similar perinuclear packets in human PASMC (Fig. 6Cb) . It must be emphasized that further study is needed to support the conclusion that the mutant channels are primarily located in packets around the nucleus.
G182R mutation in KCNA5 causes reduced channel protein expression in COS-1 cells.
To determine whether the effects of the G182R and E211D mutations on channel processing and localization were cell type specific, experiments were conducted in COS-1 cells transiently transfected with WT KCNA5, G182R, E211D, or G182R/E211D. Transfection efficiency in COS-1 cells, like that in HEK-293 cells, was 60 -80% (Fig. 7A) . COS-1 cells, like HEK-293 cells, express little endogenous KCNA5 (Fig. 2) . However, COS-1 cells transiently transfected with WT KCNA5, E211D, or G182R/ E211D express the channel protein robustly, as evident by immunoblot with anti-KCNA5 antibody (Fig. 7B) . All blots were reprobed with anti-GAPDH antibody, and all KCNA5 levels were expressed in arbitrary units normalized to GAPDH levels (Fig. 7B, bottom) . Expression levels among COS-1 cells transfected with WT KCNA5, E211D, or G182R/E211D were similar [1.02 Ϯ 0.02 a.u. for WT KCNA5 (n ϭ 4) compared with 0.98 Ϯ 0.90 a.u. for E211D (n ϭ 4) and 0.96 Ϯ 0.06 a.u. for G182R/E211D (n ϭ 4)] (Fig. 7B, bottom) . Surprisingly, expression of G182R protein in COS-1 cells was significantly reduced compared with WT KCNA5 levels and only slightly higher than in mock-transfected cells [0.17 Ϯ 0.06 a.u. for G182R (n ϭ 4) compared with 0.04 Ϯ 0.2 a.u. for mock (n ϭ 4) and 1.02 Ϯ 0.02 a.u. for WT KCNA5] (Fig. 7B) .
To verify that the diminished G182R protein level in COS-1 cells was not a result of dramatically decreased mRNA, we used RT-PCR to compare mRNA expression levels of KCNA5 in COS-1 transfected with WT KCNA5, G182R, E211D, and G182R/E211D. Although this method may not be sensitive to slight differences in mRNA in transfected cells, it was possible that a significant decrease in mRNA transcribed from the G182R plasmid would be detectable. Whole cell RNA from COS-1 cells transfected with WT-KCNA5, G182R, E211D, or G182R/E211D was isolated and subjected to standard RT-PCR protocols to detect mRNA levels of KCNA5 and GAPDH.
Mock-transfected COS-1 cells had detectable levels of KCNA5 mRNA that were significantly lower than the WT KCNA5 mRNA (1.20 Ϯ 0.04 a.u. compared with 0.81 Ϯ 0.2 a.u., P Ͻ 0.05) (Fig. 7C) . Nevertheless, there were no detectable differences in mRNA levels between COS-1 cells transfected with WT KCNA5 and G182R (1.06 Ϯ 0.08 a.u.), E211D (1.12 Ϯ 0.09 a.u.), or G182R/E211D (1.19 Ϯ 0.06 a.u.) (Fig. 7C) . Thus the decreased expression of G182R protein in COS-1 cells is not due to a complete lack of mRNA.
Overexpression of K V ␤ subunits in COS-1 cells does not rescue G182R protein expression. It was possible that the dramatic decrease in G182R protein level in COS-1 cells compared with HEK-293 cells was due to the inability of G182R protein to interact with an essential K V ␤ subunit present in COS-1 cells but absent (or not necessary) in HEK-293 cells. K V ␤1.3 is present in higher levels in COS-7 cells compared with HEK-293 cells (47) . A functional interaction between WT KCNA5 and K V ␤1.3 was confirmed by I K(V) recordings of cells transfected with WT KCNA5 alone or in the presence of HA-tagged K V ␤1.3 (K V ␤1.3-HA). As expected, I K(V) from cells transfected with WT KCNA5 alone had slow inactivation, whereas in the presence of K V ␤1.3 a distinct rapid inactivation is observed (Fig. 8) . The physical interaction of WT or mutant KCNA5 with K V ␤1.3 was examined by Co-IP in HEK-293 cells that were transfected with both WT KCNA5, G182R, E211D, or G182R/E211D and K V ␤1.3-HA. Protein fractions immunoprecipitated with anti-KCNA5 antibody were immunoblotted for the HA tag (Fig. 9Aa) . Whole cell lysate was also immunoblotted for the HA tag and served as a loading control (Fig. 9Ab) . WT KCNA5 interacts strongly with K V ␤1.3-HA (Fig. 9A, a and c) . Although the G182R and E211D mutations were expected to diminish this interaction, there was no difference among the abilities of G182R, E211D, or G182R/E211D to bind with K V ␤1.3 (0.97 Ϯ 0.21 for WT-KCNA5 compared with 1.63 Ϯ 0.60, 1.14 Ϯ 0.29, and 1.57 Ϯ 0.29 for G182R, E211D, and G182R/E211D channels, respectively; n ϭ 3) (Fig. 9Ac) .
We next tried to rescue G182R expression by overexpressing K V ␤1.2 or K V ␤1.3 (Fig. 9B ) because K V ␤ subunits are known to act as chaperones to K V channel proteins. K V ␤1 subunits (K V ␤1.2 and K V ␤1.3) were therefore coexpressed with WT KCNA5 or G182R in COS-1 cells. In COS-1 cells transfected with only WT KCNA5 or G182R, G182R protein levels were ϳ8% of WT KCNA5 (Fig. 9B) . In COS-1 cells cotransfected with either WT KCNA5 or G182R and K V ␤1.2, a similar pattern was observed, with G182R protein levels 6.38 Ϯ 2.54% of WT KCNA5 (Fig. 9B) . Similarly in COS-1 cells cotransfected with either WT KCNA5 or G182R and K V ␤1.3, G182R was expressed at 4.32 Ϯ 3.26% of WT KCNA5 levels (Fig. 9B) . Thus decreased levels of G182R protein in COS-1 cells cannot be rescued by overexpression of K V ␤ subunits.
DISCUSSION
Two mutations, G182R and E211D, which localize to the T1 domain of KCNA5 and which were found in a small population of IPAH patients, are characterized in these studies. Because both mutations occur at highly conserved residues within the conserved T1 domain, the examination of these mutations has elucidated the channel's structure-function relationship. While the T1 domain had previously been implicated in channel gating and subcellular localization and protein expression of the channels, neither the G182 nor the E211 residues had been specifically studied. Results confirm a role of the T1 domain, and specifically of these residues, in both these functions. Because interactions among K V subunits rely on polar interactions at the T1 interface, it was unexpected that the G182R and E211D proteins would be able to form functional channels. However, whole cell I K(V) recordings in HEK-293 cells transiently transfected with WT KCNA5 or mutant KCNA5 indicate that the mutant channels form functional channels. Given the experimental system used, namely transient transfection, it is possible that overexpression itself favors channel formation. To this end, it would be meaningful to create a stably transfected cell line that would allow the study of channel formation at physiologically relevant levels. However, the observed changes in mutant channel kinetics indicate that the mutations affect channel function.
While both the singly mutant channels (G182R and E211D) and the doubly mutant channel (G182R/E211D) were able to form functional channels in transiently transfected HEK-293 cells, kinetic differences between mutant and WT channels were observed. The leftward shift of the steady-state inactivation curve (and of V 1/2 ) of the G182R and G182R/E211D channels compared with the WT-KCNA5 channel was apparent. Furthermore, the G182R and G182R/E211D channels demonstrate accelerated inactivation compared with the WT-KCNA5 channel, especially at more positive prepulse potentials. Overall, these data suggest that the T1 domain is involved in channel kinetics.
The G182 and E211 residues lie close to the ion permeation pathway through the center or side portals of the T1 domain. The positive charge introduced by G182R may repel K ϩ ions to such an extent that they are less likely to enter the pore. The pore, however, favors the open conformation in the presence of high (physiological) levels of K ϩ (40, 65, 77, 78) . It is possible, then, that the G182R channel favors the inactivated state by decreasing the presence of K ϩ ions at the cytoplasmic opening of the pore. While the negative residue of the glutamic acid side chain (E211) in its WT form may be involved in attracting K ϩ ions to the pore (29), the steady-state inactivation of the E211D channel was found to be similar to that of the WT channel. Thus it does not seem likely that this residue is important for channel open stabilization or attraction of K ϩ ions. Interestingly, a valine to arginine mutation in Aplysia KCNA1 (9), which lies on the same linker between two ␣-helices in the T1 domain as G182R, causes a decrease in channel activation rates, thus implicating the linker in channel kinetics. This mutation did not alter either overall T1 conformation or the stability of T1 interactions, leading the authors to postulate that the mutation had its effects through local action of the amino acid (9) . T1 mutations have also been found to affect channel gating through conformational changes. The G182R residue lies on the polar interface of T1, which is important for subunit interactions. A glutamine two residues upstream of the homologous G182 residue in KCNA2 is completely intolerant to alanine mutation, because the mutant protein fails to form functional channels (39) . On the basis of this evidence and mutational analysis of other T1 domain residues, the authors concluded that structural changes in the buried polar interfaces of the T1 core play a role in conformational changes associated with channel opening (39) . Therefore, it is possible that G182R, by introducing local changes in T1 structure, affects channel kinetics, although such sophisticated modeling was beyond the scope of these studies.
Slow inactivation in KCNA5 is incompletely understood but may depend on a collapse of the channel pore and/or the NH 2 3 and 4) or KV␤1.3 (lanes 5 and 6) . a: Protein lysate from these cells was subjected to standard immunoblot to detect KCNA5 (67 kDa) or GAPDH (36 kDa). b: WT KCNA5 and G182R protein levels were normalized to GAPDH and are summarized in arbitrary units. NS, no significant difference (ANOVA with Tukey post hoc test, P Ͼ 0.05) compared with G182R-KV␤. Data are presented as means Ϯ SE; n ϭ 3.
terminus (24, 44, 69) . If the G182R mutation destabilizes the pore open conformation by decreasing local K ϩ ion concentrations, then a collapse of the channel pore may explain the faster inactivation conferred by the mutations. Regardless of the exact mechanism of faster inactivation, at potentials less negative than the resting E m (between Ϫ40 and Ϫ70 mV), K V channels open to repolarize the membrane. In neurons and cardiomyocytes, this influences the duration of the action potential. In PASMC, the rate of repolarization would influence the duration that voltage-dependent Ca 2ϩ channels (VDCC) remain open after a depolarization. The G182R and G182R/E211D channels, therefore, would increase the duration of VDCC opening (as a result of accelerated inactivation), thus enhancing the influx of Ca 2ϩ compared with the WT channel. However, at potentials more negative than Ϫ40 mV, the main function of K V channels is to maintain the resting E m . Compared with WT KCNA5, both G182R and G182R/E211D channels may cause membrane depolarization by increasing the rate of KCNA5 inactivation.
While altered inactivation kinetics of mutant KCNA5 was observed, the channels must get to the plasma membrane for kinetic effects to be relevant. The observed patterns of mutant KCNA5 subcellular localization and protein processing suggest that the channels, especially the G182R channel, may not be efficiently localized to the plasma membrane. KCNA5 channels, like all proteins, are subject to regulation during biosynthesis. KCNA5 is a surface protein in the plasma membrane and has a glycosylation site on its extracellular loop between S1 and S2. In WT KCNA5-transfected HEK-293 cells, the channel is present mostly in its mature form, whereas both the G182R and G182R/E211D channels were present in greater proportions in their immature forms. Immunostaining against KCNA5 in HEK-293 cells demonstrated that while cells transfected with WT KCNA5 had both perinuclear and surface staining, the G182R protein localized mainly to perinuclear packets, with little present on the cell surface. E211D and G182R/E211D staining were seen both on the cell surface and in perinuclear packets. Transfected COS-1 cells were subjected to similar studies to determine whether the effects of the mutations were cell type specific. Unexpectedly, G182R protein was present in significantly reduced amounts in COS-1 cells, an effect that depended neither on the proteasome (data not shown) nor on K V ␤ subunits (Fig. 9) .
It is possible that the mutant protein, rather than being targeted to the proteasome, is sent to the lysosome for degradation. In this pathway, proteins expressed on the cell surface are internalized and broken down in the acidic environment of the lysosome. Recent evidence has pointed to the important role lysosomes play in the regulation of K ϩ channel expression. It has previously been reported that the voltage-gated K ϩ channel HERG, after internalization and ubiquitinization, is targeted to lysosomes (16) . The lysosomal pathway is also involved in the degradation of K IR channels (20) . If, at any given time, a portion of mutant channels is expressed on the cell surface and a portion is internalized for degradation, this would explain the dual pattern of staining observed in cells that had both perinuclear and cell surface staining. While we did not investigate the relationship between KCNA5 (WT and mutant) proteins and the lysosome in this study, it is certainly possible that dysfunctional protein at the channel surface leads to its internalization and subsequent degradation.
Interestingly, in transfected human PASMC, WT KCNA5 was observed in a diffuse pattern throughout the cell, while G182R, E211D, and G182R/E211D were present in distinct clusters around the nucleus. Subtle effects of KCNA5 mutations may not be observable in transiently transfected cells. However, in PASMC, where KCNA5 is one of the dominant K V channel subtypes expressed, a reduction in KCNA5 levels or a reduction of expression at the cell surface may very well be detrimental to the cell, resulting in decreased I K(V) and relatively depolarized cell membrane. This would lead to increased [Ca 2ϩ ] cyt and enhanced contraction, migration, and proliferation.
Overexpression of K V ␤ subunits was unable to rescue protein levels of G182R in COS-1 cells. Therefore there may be another unknown chaperone protein that associates with KCNA5 (and the E211D and G182R/E211D channels) in COS-1 cells that is absent in HEK-293 cells. SH3 and PDZbinding domains in the NH 2 terminus of KCNA5 allow interactions with proteins other than K V ␤ subunits, including Src tyrosine kinase, PSD95, and SAP97 (11, 12, 19, 37) . KCNA5 can also associate with ␣-actinin-2 through its NH 2 -terminal region, thus linking it to the actin cytoskeleton (36) . Alternatively, there may be a KCNA5-associated protein that negatively regulates its expression (and binds only to the G182R channel) and is present in COS-1 cells but not in HEK-293 cells.
It is surprising that while G182R protein levels were markedly reduced in COS-1 cells, this effect was not observed for the G182R/E211D protein, as though the E211D mutation rescues the G182R phenotype. This may be the result of simple steric hindrance. For example, if a chaperone protein relies on a positively charged interface to interact with the negative side chain of E211 in WT KCNA5 channel expression, this interaction may be preserved in E211D and G182R/E211D channels. However, the presence of the positive side chain of the G182R group in the context of E211 may prevent this interaction by repellent positive charges. In the doubly mutant channel, however, the negatively charged group, because of the shorter side chain of aspartate compared with glutamate, may be sufficiently distant from the positive guanidinium group to allow the interaction between KCNA5 and the hypothetical chaperone protein. Of course, there may be a variety of regulatory and/or adaptor proteins that interact with these specific residues of the T1 domain of KCNA5. As noted above, the differences in expression patterns of G182R, E211D, and G182R/E211D between HEK-293 and COS-1 cell types may be due to differential expression of regulatory proteins (other than K V ␤1.3) in these cells. For example, even in two mammalian cell lines (mouse L cells and HEK-293 cells), dramatic differences in current properties from transfected KCNA5 were found to exist (62) . Similarly, the effects of KCNA5 mutant variants were observed in Chinese hamster ovary (CHO) cells but not in HEK-293 cells (46) , further suggesting the sensitivity of channel function to specific cell backgrounds. Additionally, in cells that express KCNA5 heterotetramers, G182R subunits may act in a dominant-negative fashion, associating with other K V subunits and decreasing their surface expression and/or protein levels. That certain KCNA subunits are capable of acting in such a dominant-negative manner is not without precedent (14, 33, 64) . Moreover, in cell types such as PASMC that rely mainly on KCNA5 channels to maintain resting E m , a lack of functional KCNA5 at the cell surface may lead to an overall depolarization.
In summary, the nonsynonymous SNP in KCNA5 that leads to the amino acid change from glycine to arginine (G182R) in the T1 domain significantly alters the inactivation kinetics of KCNA5 and markedly affects the channel protein localization onto the plasma membrane. Additionally, the E211 residue may be involved in the interaction of KCNA5 with regulatory proteins. The naturally existing SNPs in KCNA5 may predispose individuals who bear these SNPs to high risk for conditions and diseases related to dysfunctional K V channels.
